Drug Side Effects
Search
ACETAMINOPHEN AND IBUPROFEN
ACETAMINOPHEN AND IBUPROFEN
was reported 220 times
These side effects are most commonly reported by patients taking ACETAMINOPHEN AND IBUPROFEN:
#
Side effect
Count
0
DRUG INEFFECTIVE
47
1
DRUG EFFECTIVE FOR UNAPPROVED INDICATION
30
2
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
27
3
DRUG EFFECT LESS THAN EXPECTED
15
4
UNDERDOSE
13
5
OVERDOSE
10
6
INCORRECT DOSE ADMINISTERED
9
7
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION
8
8
HYPERSENSITIVITY
8
9
OFF LABEL USE
7
10
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
6
11
DRUG HYPERSENSITIVITY
5
12
MALAISE
4
13
SOMNOLENCE
4
14
DIARRHOEA
3
15
FATIGUE
3
16
INJECTION SITE BRUISING
3
17
OROPHARYNGEAL PAIN
3
18
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS
3
19
ABDOMINAL DISCOMFORT
2
20
ABDOMINAL PAIN UPPER
2
21
ANXIETY
2
22
ASTHENIA
2
23
CARDIAC FAILURE
2
24
CONSTIPATION
2
25
DEFAECATION URGENCY
2
26
DRUG DEPENDENCE
2
27
DYSPNOEA
2
28
EXTRA DOSE ADMINISTERED
2
29
FEELING ABNORMAL
2
30
GASTROENTERITIS VIRAL
2
31
HEADACHE
2
32
INCORRECT PRODUCT ADMINISTRATION DURATION
2
33
INSOMNIA
2
34
INTENTIONAL PRODUCT USE ISSUE
2
35
PRODUCT USE IN UNAPPROVED INDICATION
2
36
SINUSITIS
2
37
THERAPEUTIC PRODUCT EFFECT DECREASED
2
38
THERAPEUTIC PRODUCT EFFECT VARIABLE
2
39
THROAT IRRITATION
2
40
VOMITING
2
41
ABDOMINAL PAIN
1
42
ACUTE KIDNEY INJURY
1
43
ARTHRALGIA
1
44
BLOOD GLUCOSE INCREASED
1
45
BRAIN OEDEMA
1
46
CARDIAC DISORDER
1
47
CATHETER SITE PAIN
1
48
CHEST PAIN
1
49
CHRONIC RESPIRATORY FAILURE
1
50
CONDITION AGGRAVATED
1
51
CORNEAL PERFORATION
1
52
CORONAVIRUS INFECTION
1
53
COUGH
1
54
COVID-19
1
55
CYSTITIS
1
56
DEATH
1
57
DEPRESSION
1
58
DEVICE ISSUE
1
59
DIAPHRAGMATIC PARALYSIS
1
60
DISEASE RECURRENCE
1
61
DIZZINESS
1
62
DRUG SCREEN POSITIVE
1
63
DYSBIOSIS
1
64
DYSGEUSIA
1
65
DYSPEPSIA
1
66
EXPIRED PRODUCT ADMINISTERED
1
67
FEELING DRUNK
1
68
FLATULENCE
1
69
GASTRITIS
1
70
GASTROINTESTINAL DISORDER
1
71
HAEMATOCHEZIA
1
72
HAEMORRHAGE
1
73
HEPATIC FAILURE
1
74
HOSPITALISATION
1
75
HOT FLUSH
1
76
HYPERTENSION
1
77
INCREASED NEED FOR SLEEP
1
78
INFLUENZA LIKE ILLNESS
1
79
INJECTION SITE ERYTHEMA
1
80
INJECTION SITE PRURITUS
1
81
INJECTION SITE SWELLING
1
82
INJECTION SITE WARMTH
1
83
INTENTIONAL DOSE OMISSION
1
84
INTENTIONAL OVERDOSE
1
85
KERATITIS
1
86
KIDNEY INFECTION
1
87
LIVER DISORDER
1
88
LIVER INJURY
1
89
MOBILITY DECREASED
1
90
MUSCULOSKELETAL DISCOMFORT
1
91
NASAL CONGESTION
1
92
NASOPHARYNGITIS
1
93
NAUSEA
1
94
NOCTURIA
1
95
OBLITERATIVE BRONCHIOLITIS
1
96
PAIN
1
97
PALPITATIONS
1
98
PARAESTHESIA
1
99
PERICARDITIS
1
100
PNEUMOMEDIASTINUM
1
101
PNEUMONIA
1
102
PNEUMOTHORAX
1
103
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE
1
104
PRODUCT AFTER TASTE
1
105
PRODUCT DOSE OMISSION ISSUE
1
106
PRODUCT FORMULATION ISSUE
1
107
PRODUCT QUALITY ISSUE
1
108
PRODUCT SOLUBILITY ABNORMAL
1
109
PRODUCT USE COMPLAINT
1
110
PRURITUS
1
111
PSEUDOMONAS INFECTION
1
112
PSORIATIC ARTHROPATHY
1
113
PYREXIA
1
114
RASH
1
115
RESPIRATORY DISORDER
1
116
RESTLESS LEGS SYNDROME
1
117
RHINORRHOEA
1
118
ROTATOR CUFF SYNDROME
1
119
SENSITIVE SKIN
1
120
SKIN DISCOLOURATION
1
121
STEVENS-JOHNSON SYNDROME
1
122
SURGERY
1
123
THERAPEUTIC PRODUCT EFFECT DELAYED
1
124
THERAPEUTIC RESPONSE UNEXPECTED
1
125
ULCER HAEMORRHAGE
1
126
ULCERATIVE KERATITIS
1
127
URINARY TRACT INFECTION
1
128
URTICARIA
1